Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 502.429, 502.430, 502.431 | Other Identifier | Boehringer Ingelheim |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study to obtain long-term data on effects, safety and tolerability in routine medical practice and to investigate the potential of telmisartan to prevent secondary organ damage
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hypertension patients - Pneumology |
| ||
| Hypertension patients - Cardiology |
| ||
| Hypertension patients - Nephrology |
| ||
| Hypertension patients - Diabetology |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Micardis® | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with adverse events | up to 1 year | |
| Number of patients with abnormal changes in laboratory parameters | up to 1 year | |
| Number of patients with clinically significant changes in vital signs | up to 1 year | |
| Change in systolic blood pressure | up to 1 year | |
| Change in diastolic blood pressure | up to 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Global assessment of efficacy by investigator on a 4-point scale | 2 weeks, after 1 year | |
| Global assessment of tolerability by investigator on a 4-point scale | 2 weeks, after 1 year |
Not provided
Inclusion Criteria:
No additional selection criteria have to be considered. Treatment was at the discretion of the physician following the summary of product information for Micardis® and MicardisPlus®
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with hypertension recruited at hospitals in Germany specialized in cardiology, nephrology, diabetology and pneumology
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077333 | Telmisartan |
| C436283 | telmisartan, hydrochlorothiazide drug combination |
| ID | Term |
|---|---|
| D001713 | Biphenyl Compounds |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
Not provided
Not provided
Not provided
Not provided
Not provided
| MicardisPlus® | Drug |
|
| D006838 |
| Hydrocarbons |
| D009930 | Organic Chemicals |
| D001562 | Benzimidazoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |